How to implant the new Amplatzer amulet: a step-by-step procedureJ. Camm
provided superior left atrial appendage (LAA) closure over the old-guard Watchman (Boston Scientific) device but failed to significantly cut stroke or bleeding rates in patients with atrial fibrillation, despite theoretical advantages in its design and the ability to forgo post-implant oral ...
The ACP-2 is a second-generation device developed to reduce implant- related complications and increase sealing capacity on a wide range of LAA anatomies.4 Generally, percutaneous LAA closure has a low rate of complications. However, adverse events such as pericardial effusion, device thrombosis, ...
LAAo was performed underconscious sedationin all patients with a mean procedure time of 37 ± 12 min; the mean device size was 24 ± 3 mm. During LAAo, 37 ± 36 ml of contrast dye were used. LAAo was successful in all patients. Peri-interventional complications occurred in 2 of 24 ...
Despite our patient's history of failing Watchman deployment, he was discharged on the same day after implant of the Amulet device without post-procedure TTE. We postulate that the Amulet device dislodged shortly after deployment and was held within the left atrium by the MitraClip until ...
We planned to implant an Amplatzer‐Amulet 25 mm LAA occluder through the dedicated 12F delivery sheath. After starting the tug test, TEE suddenly showed a floating thrombus whose proximal part was connected to the delivery cable. Because transesophageal echocardiography showed a good position of the...